Respiratory Inhalers Market to 2027 - Global Analysis and Forecasts by Product (Dry Powder Inhaler, Metered Dose Inhaler, and Nebulizer), Technology (Manually Operated Inhaler Devices and Digitally Operated Inhaler Devices), Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Other Respiratory Diseases), and Geography
Report Code: TIPRE00003093 No. of Pages: 150 Category: Medical Device Status: Upcoming
Inhalers for respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma are medical devices which deliver medicine to prevent, control and treat symptoms and help reduce exacerbations. There are many different types of inhaler, these variations can be confusing. The medicine inside an inhaler goes directly into the airways when the patient breathe in. Hence the patient requires much smaller dose of the medicine as compared to tablet or liquid.
The respiratory inhalers market is anticipated to grow in the forecast period owing to key factors such as increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD), reduced patient discomfort for inhalers, and technological advancements in respiratory inhaler devices. Moreover, regulatory approvals for new and advanced respiratory inhaler pose growing opportunities for the growth of the global respiratory inhalers market.
The "Global Respiratory Inhalers Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global respiratory inhaler market with detailed market segmentation by product, technology, disease indication and geography. The global respiratory inhaler market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading respiratory inhaler market players and offers key trends and opportunities in the market.
The global respiratory inhalers market is segmented on the basis of product, technology, and disease indication. Based on product, the respiratory inhaler market is segmented as dry powder inhaler, metered dose inhaler, nebulizer. The nebulizer market is further segmented into mesh nebulizers, ultrasonic nebulizers, and compressed air nebulizers. By technology the market is segmented into manually operated inhaler devices and digitally operated inhaler devices. Based on disease indication, the respiratory inhaler market is segmented as asthma, COPD, pulmonary arterial hypertension and others respiratory disease.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global respiratory inhalers market based on product, technology, and disease indication. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The respiratory inhalers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the respiratory inhalers market in the forecast period, due to the increasing prevalence COPD and asthma. Increase in number of patients affected by these diseases, increases the demand for respiratory inhalers, thereby boosting growth of this region. Also, availability of technologically advanced products in this region as well as the presence of major market players in this region contribute to the market growth. However, Asia Pacific region is expected to be the fastest growing region owing to availability of several untapped opportunities, growing awareness about the treatment of respiratory disorders amongst patients by supportive nongovernment organizations, such as the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) and increasing adoption rate of respiratory devices in Asian countries, such as India and China.
The report analyzes factors affecting respiratory inhalers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the respiratory inhalers market in these regions.
The report also includes the profiles of key respiratory inhaler companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the respiratory inhaler market include AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cipla Inc, GlaxoSmithKline, Koninklijke Philips N.V., OMRON Healthcare Europe B.V, PARI, Gecko Health, and Inspiro Medical among others.
The respiratory inhalers market is anticipated to grow in the forecast period owing to key factors such as increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD), reduced patient discomfort for inhalers, and technological advancements in respiratory inhaler devices. Moreover, regulatory approvals for new and advanced respiratory inhaler pose growing opportunities for the growth of the global respiratory inhalers market.
The "Global Respiratory Inhalers Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global respiratory inhaler market with detailed market segmentation by product, technology, disease indication and geography. The global respiratory inhaler market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading respiratory inhaler market players and offers key trends and opportunities in the market.
The global respiratory inhalers market is segmented on the basis of product, technology, and disease indication. Based on product, the respiratory inhaler market is segmented as dry powder inhaler, metered dose inhaler, nebulizer. The nebulizer market is further segmented into mesh nebulizers, ultrasonic nebulizers, and compressed air nebulizers. By technology the market is segmented into manually operated inhaler devices and digitally operated inhaler devices. Based on disease indication, the respiratory inhaler market is segmented as asthma, COPD, pulmonary arterial hypertension and others respiratory disease.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global respiratory inhalers market based on product, technology, and disease indication. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The respiratory inhalers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the respiratory inhalers market in the forecast period, due to the increasing prevalence COPD and asthma. Increase in number of patients affected by these diseases, increases the demand for respiratory inhalers, thereby boosting growth of this region. Also, availability of technologically advanced products in this region as well as the presence of major market players in this region contribute to the market growth. However, Asia Pacific region is expected to be the fastest growing region owing to availability of several untapped opportunities, growing awareness about the treatment of respiratory disorders amongst patients by supportive nongovernment organizations, such as the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) and increasing adoption rate of respiratory devices in Asian countries, such as India and China.
The report analyzes factors affecting respiratory inhalers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the respiratory inhalers market in these regions.
The report also includes the profiles of key respiratory inhaler companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the respiratory inhaler market include AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cipla Inc, GlaxoSmithKline, Koninklijke Philips N.V., OMRON Healthcare Europe B.V, PARI, Gecko Health, and Inspiro Medical among others.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Respiratory Inhalers Market- By Product
1.3.2. Respiratory Inhalers Market- By Technology
1.3.3. Respiratory Inhalers Market- By Disease Indication
1.3.4. Respiratory Inhalers Market- By Region
1.3.4.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RESPIRATORY INHALERS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis
5. RESPIRATORY INHALERS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RESPIRATORY INHALERS MARKET- GLOBAL ANALYSIS
6.1. RESPIRATORY INHALERS MARKET - GLOBAL MARKET OVERVIEW
6.2. RESPIRATORY INHALERS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. RESPIRATORY INHALERS MARKET REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. NEBULIZER MARKET
7.3.1. Overview
7.3.2. Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.3. Compressed Air Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.3.1. Overview
7.3.3.2. Compressed Air Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.4. Ultrasonic Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.4.1. Overview
7.3.4.2. Ultrasonic Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.5. Mesh Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.5.1. Overview
7.3.5.2. Mesh Nebulizers Market Forecast and Analysis (US$ Mn)
7.4. METERED DOSE INHALERS MARKET
7.4.1. Overview
7.4.2. Metered Dose Inhalers Market Forecast and Analysis (US$ Mn)
7.5. DRY POWDER INHALERS MARKET
7.5.1. Overview
7.5.2. Dry Powder Inhalers Market Forecast and Analysis (US$ Mn)
8. RESPIRATORY INHALERS MARKET REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. MANUALLY OPERATED INHALERS MARKET
8.3.1. Overview
8.3.2. Manually Operated Inhalers Market Forecast and Analysis (US$ Mn)
8.4. DIGITALLY OPERATED INHALERS MARKET
8.4.1. Overview
8.4.2. Digitally Operated Inhalers Market Forecast and Analysis (US$ Mn)
9. RESPIRATORY INHALERS MARKET REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
9.1. OVERVIEW
9.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
9.3. ASTHMA MARKET
9.3.1. Overview
9.3.2. Asthma Market Forecast and Analysis (US$ Mn)
9.4. COPD MARKET
9.4.1. Overview
9.4.2. COPD Market Forecast and Analysis (US$ Mn)
9.5. PULMONARY ARTERIAL HYPERTENSION MARKET
9.5.1. Overview
9.5.2. Pulmonary Arterial Hypertension Market Forecast and Analysis (US$ Mn)
9.6. OTHER RESPIRATORY DISEASES MARKET
9.6.1. Overview
9.6.2. Other Respiratory Diseases Market Forecast and Analysis (US$ Mn)
10. RESPIRATORY INHALERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA RESPIRATORY INHALERS MARKET
10.1.1. North America Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.1.2.1. North America Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.1.3. North America Respiratory Inhalers Market Forecasts and Analysis - By Type (US$ Mn)
10.1.4. North America Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.1.5. North America Respiratory Inhalers Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.1.6.1.1. US Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.2. US Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.6.3. US Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.1.7.1.1. Canada Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.2. Canada Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.7.3. Canada Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.1.8.1.1. Mexico Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.2. Mexico Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.8.3. Mexico Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2. EUROPE RESPIRATORY INHALERS MARKET
10.2.1. Europe Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.2.1. Europe Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.3. Europe Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.4. Europe Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.5. Europe Respiratory Inhalers Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.6.1.1. UK Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.2. UK Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.6.3. UK Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Germany Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.7.1.1. Germany Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.2. Germany Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.7.3. Germany Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.8.1.1. France Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.2. France Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.8.3. France Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.9. Italy Market Overview
10.2.9.1. Italy Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.9.1.1. Italy Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.9.2. Italy Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.9.3. Italy Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.10. Spain Market Overview
10.2.10.1. Spain Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.10.1.1. Spain Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.10.2. Spain Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.10.3. Spain Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3. ASIA PACIFIC RESPIRATORY INHALERS MARKET
10.3.1. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.2.1. Asia Pacific Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.3. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.4. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.5. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis - By Country
10.3.6. China Market Overview
10.3.6.1. China Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.6.1.1. China Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.2. China Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.6.3. China Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.7. Japan Market Overview
10.3.7.1. Japan Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.7.1.1. Japan Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.2. Japan Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.7.3. Japan Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.8. India Market Overview
10.3.8.1. India Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.8.1.1. India Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.2. India Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.8.3. India Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.9. South Korea Market Overview
10.3.9.1. South Korea Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.9.1.1. South Korea Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.9.2. South Korea Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.9.3. South Korea Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.10. Australia Market Overview
10.3.10.1. Australia Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.10.1.1. Australia Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.10.2. Australia Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.10.3. Australia Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.4. MIDDLE EAST AND AFRICA (MEA) RESPIRATORY INHALERS MARKET
10.4.1. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.4.2.1. Middle East and Africa (MEA) Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.4.3. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.4. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.4.5. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis - By Country
10.4.6. UAE Market Overview
10.4.6.1. UAE Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.4.6.1.1. UAE Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.2. UAE Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.6.3. UAE Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.4.7.1.1. Saudi Arabia Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.2. Saudi Arabia Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.7.3. Saudi Arabia Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.4.8. South Africa Market Overview
10.4.8.1. South Africa Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.4.8.1.1. South Africa Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.2. South Africa Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.8.3. South Africa Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA RESPIRATORY INHALERS MARKET
10.5.1. South and Central America Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.5.2.1. South and Central America Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.5.3. South and Central America Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.4. South and Central America Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.5.5. South and Central America Respiratory Inhalers Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.5.6.1.1. Brazil Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.2. Brazil Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.6.3. Brazil Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.5.7. Argentina Market Overview
10.5.7.1. Argentina Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.5.7.1.1. Argentina Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.5.7.2. Argentina Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.7.3. Argentina Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions
12. RESPIRATORY INHALERS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BEXIMCO PHARMACEUTICALS LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CIPLA INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. KONINKLIJKE PHILIPS N.V.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. OMRON HEALTHCARE EUROPE B.V
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PARI
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GLAXOSMITHKLINE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GECKO HEALTH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INSPIRO MEDICAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Respiratory Inhalers Market- By Product
1.3.2. Respiratory Inhalers Market- By Technology
1.3.3. Respiratory Inhalers Market- By Disease Indication
1.3.4. Respiratory Inhalers Market- By Region
1.3.4.1. By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RESPIRATORY INHALERS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis
5. RESPIRATORY INHALERS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RESPIRATORY INHALERS MARKET- GLOBAL ANALYSIS
6.1. RESPIRATORY INHALERS MARKET - GLOBAL MARKET OVERVIEW
6.2. RESPIRATORY INHALERS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. RESPIRATORY INHALERS MARKET REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. NEBULIZER MARKET
7.3.1. Overview
7.3.2. Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.3. Compressed Air Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.3.1. Overview
7.3.3.2. Compressed Air Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.4. Ultrasonic Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.4.1. Overview
7.3.4.2. Ultrasonic Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.5. Mesh Nebulizers Market Forecast and Analysis (US$ Mn)
7.3.5.1. Overview
7.3.5.2. Mesh Nebulizers Market Forecast and Analysis (US$ Mn)
7.4. METERED DOSE INHALERS MARKET
7.4.1. Overview
7.4.2. Metered Dose Inhalers Market Forecast and Analysis (US$ Mn)
7.5. DRY POWDER INHALERS MARKET
7.5.1. Overview
7.5.2. Dry Powder Inhalers Market Forecast and Analysis (US$ Mn)
8. RESPIRATORY INHALERS MARKET REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. MANUALLY OPERATED INHALERS MARKET
8.3.1. Overview
8.3.2. Manually Operated Inhalers Market Forecast and Analysis (US$ Mn)
8.4. DIGITALLY OPERATED INHALERS MARKET
8.4.1. Overview
8.4.2. Digitally Operated Inhalers Market Forecast and Analysis (US$ Mn)
9. RESPIRATORY INHALERS MARKET REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
9.1. OVERVIEW
9.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
9.3. ASTHMA MARKET
9.3.1. Overview
9.3.2. Asthma Market Forecast and Analysis (US$ Mn)
9.4. COPD MARKET
9.4.1. Overview
9.4.2. COPD Market Forecast and Analysis (US$ Mn)
9.5. PULMONARY ARTERIAL HYPERTENSION MARKET
9.5.1. Overview
9.5.2. Pulmonary Arterial Hypertension Market Forecast and Analysis (US$ Mn)
9.6. OTHER RESPIRATORY DISEASES MARKET
9.6.1. Overview
9.6.2. Other Respiratory Diseases Market Forecast and Analysis (US$ Mn)
10. RESPIRATORY INHALERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA RESPIRATORY INHALERS MARKET
10.1.1. North America Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.1.2.1. North America Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.1.3. North America Respiratory Inhalers Market Forecasts and Analysis - By Type (US$ Mn)
10.1.4. North America Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.1.5. North America Respiratory Inhalers Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.1.6.1.1. US Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.2. US Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.6.3. US Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.1.7.1.1. Canada Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.2. Canada Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.7.3. Canada Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.1.8.1.1. Mexico Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.2. Mexico Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.8.3. Mexico Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2. EUROPE RESPIRATORY INHALERS MARKET
10.2.1. Europe Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.2.1. Europe Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.3. Europe Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.4. Europe Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.5. Europe Respiratory Inhalers Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.6.1.1. UK Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.2. UK Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.6.3. UK Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Germany Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.7.1.1. Germany Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.2. Germany Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.7.3. Germany Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.8.1.1. France Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.2. France Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.8.3. France Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.9. Italy Market Overview
10.2.9.1. Italy Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.9.1.1. Italy Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.9.2. Italy Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.9.3. Italy Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.2.10. Spain Market Overview
10.2.10.1. Spain Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.2.10.1.1. Spain Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.2.10.2. Spain Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.10.3. Spain Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3. ASIA PACIFIC RESPIRATORY INHALERS MARKET
10.3.1. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.2.1. Asia Pacific Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.3. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.4. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.5. Asia Pacific Respiratory Inhalers Market Forecasts and Analysis - By Country
10.3.6. China Market Overview
10.3.6.1. China Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.6.1.1. China Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.2. China Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.6.3. China Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.7. Japan Market Overview
10.3.7.1. Japan Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.7.1.1. Japan Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.2. Japan Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.7.3. Japan Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.8. India Market Overview
10.3.8.1. India Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.8.1.1. India Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.2. India Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.8.3. India Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.9. South Korea Market Overview
10.3.9.1. South Korea Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.9.1.1. South Korea Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.9.2. South Korea Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.9.3. South Korea Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.3.10. Australia Market Overview
10.3.10.1. Australia Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.3.10.1.1. Australia Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.3.10.2. Australia Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.10.3. Australia Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.4. MIDDLE EAST AND AFRICA (MEA) RESPIRATORY INHALERS MARKET
10.4.1. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.4.2.1. Middle East and Africa (MEA) Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.4.3. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.4. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.4.5. Middle East and Africa (MEA) Respiratory Inhalers Market Forecasts and Analysis - By Country
10.4.6. UAE Market Overview
10.4.6.1. UAE Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.4.6.1.1. UAE Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.2. UAE Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.6.3. UAE Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.4.7.1.1. Saudi Arabia Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.2. Saudi Arabia Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.7.3. Saudi Arabia Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.4.8. South Africa Market Overview
10.4.8.1. South Africa Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.4.8.1.1. South Africa Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.2. South Africa Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.8.3. South Africa Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA RESPIRATORY INHALERS MARKET
10.5.1. South and Central America Respiratory Inhalers Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.5.2.1. South and Central America Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.5.3. South and Central America Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.4. South and Central America Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.5.5. South and Central America Respiratory Inhalers Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.5.6.1.1. Brazil Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.2. Brazil Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.6.3. Brazil Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
10.5.7. Argentina Market Overview
10.5.7.1. Argentina Respiratory Inhalers Market Forecasts and Analysis - By Product (US$ Mn)
10.5.7.1.1. Argentina Nebulizer Market Forecasts and Analysis - By Type (US$ Mn)
10.5.7.2. Argentina Respiratory Inhalers Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.7.3. Argentina Respiratory Inhalers Market Forecasts and Analysis - By Disease Indication (US$ Mn)
11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions
12. RESPIRATORY INHALERS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BEXIMCO PHARMACEUTICALS LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CIPLA INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. KONINKLIJKE PHILIPS N.V.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. OMRON HEALTHCARE EUROPE B.V
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PARI
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GLAXOSMITHKLINE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GECKO HEALTH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INSPIRO MEDICAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. AstraZeneca
2. Beximco Pharmaceuticals Ltd.
3. Boehringer Ingelheim International GmbH
4. Cipla Inc
5. GlaxoSmithKline
6. Koninklijke Philips N.V.
7. OMRON Healthcare Europe B.V
8. PARI
9. Gecko Health
10. Inspiro Medical
1. AstraZeneca
2. Beximco Pharmaceuticals Ltd.
3. Boehringer Ingelheim International GmbH
4. Cipla Inc
5. GlaxoSmithKline
6. Koninklijke Philips N.V.
7. OMRON Healthcare Europe B.V
8. PARI
9. Gecko Health
10. Inspiro Medical